Consolidated Statements of Changes in Equity (Unaudited) - USD ($) $ in Thousands	Total Stockholder's Equity	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Accumulated Other Comprehensive Loss	Treasury Stock	Deferred Compensation	Noncontrolling Interests	Total
Beginning Balance at Oct. 31, 2022	$ 684,392	$ 41	$ 2,094,076	$ (1,407,973)	$ (1,752)	$ (855)	$ 855	$ 7,105	$ 691,497
Beginning Balance at (in shares) at Oct. 31, 2022		405,562,988
Common stock issued, non-employee compensation	68		68						68
Common stock issued, non-employee compensation (in shares)		21,106
Stock issued under benefit plans, net of taxes paid upon vesting of restricted stock awards	(314)		(314)						(314)
Stock issued under benefit plans, net of taxes paid upon vesting of restricted stock awards (in shares)		169,065
Share based compensation	2,637		2,637						2,637
Preferred dividends - Series B	(800)		(800)						(800)
Effect of foreign currency translation	447				447				447
Adjustment for deferred compensation						(68)	68
Adjustment for deferred compensation (in shares)		(21,106)
Reclassification of redeemable non-controlling interest								3,030	3,030
Distribution to non-controlling interest								(106)	(106)
Net loss attributable to noncontrolling interests	2,464			2,464				(2,464)	2,464
Net Loss	(21,086)			(21,086)					(21,086)
Ending Balance at Jan. 31, 2023	667,808	$ 41	2,095,667	(1,426,595)	(1,305)	(923)	923	7,565	675,373
Ending Balance at (in shares) at Jan. 31, 2023		405,732,053
Beginning Balance at Oct. 31, 2023	682,493	$ 45	2,199,661	(1,515,541)	(1,672)	(1,078)	1,078	17,955	$ 700,448
Beginning Balance at (in shares) at Oct. 31, 2023		450,626,862							450,626,862
Common stock issued, non-employee compensation	51		51						$ 51
Common stock issued, non-employee compensation (in shares)		44,398
Stock issued under benefit plans, net of taxes paid upon vesting of restricted stock awards	(926)		(926)						(926)
Stock issued under benefit plans, net of taxes paid upon vesting of restricted stock awards (in shares)		1,235,192
Share based compensation	2,876		2,876						2,876
Preferred dividends - Series B	(800)		(800)						(800)
Effect of foreign currency translation	33				33				33
Adjustment for deferred compensation						(51)	51
Adjustment for deferred compensation (in shares)		(44,398)
Contributions received from sale of noncontrolling interest								25,122	25,122
Distribution to non-controlling interest								(236)	(236)
Net loss attributable to noncontrolling interests	24,606			24,606				(24,606)	24,606
Net Loss	(44,399)			(44,399)					(44,399)
Ending Balance at Jan. 31, 2024	$ 663,934	$ 45	$ 2,200,862	$ (1,535,334)	$ (1,639)	$ (1,129)	$ 1,129	$ 18,235	$ 682,169
Ending Balance at (in shares) at Jan. 31, 2024		451,862,054							451,862,054